Your session is about to expire
← Back to Search
VOLITE XC Injectable Gel for Neck Lines
Study Summary
This trial is being conducted to assess the safety and effectiveness of VOLITE XC, an injectable gel, for the improvement of horizontal neck lines.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowTimeline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Side effects data
From undefined Phase 3 trial • 332 Patients • NCT01240382Trial Design
Find a Location
Who is running the clinical trial?
Media Library
- I have skin color changes on my neck that could affect skin checks.I haven't had cosmetic procedures on my neck in the last year.I have a noticeable neck deformity or very loose skin with deep folds.I haven't had HA fillers or fat injections in my neck in the last year.I want to improve the horizontal lines on my neck.I haven't had fat reduction treatments under my chin in the last 6 months.I have had surgery or procedures on my neck.I do not have any skin infections, wounds, or cancerous lesions on my neck.I have not had soft tissue fillers in my neck in the last 2 years.I have moderate to severe horizontal neck lines.I haven't had botulinum toxin in my neck in the last 6 months.I have had thyroid or skin cancer in the neck, radiation there, or a new cancer in that area.
- Group 1: VOLITE XC
- Group 2: Control Group
- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
- Pivotal Trial - The final step before approval, pivotal trials feature drugs that have already shown basic safety & efficacy.
- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
To how many patients does this trial have access?
"This trial is based in Mariwalla Dermatology in West Islip, New york; Research Institute of the Southeast, LLC in West Palm Beach, Florida; Skin And Aesthetics Surgery Of Manhattan in New York, District of Columbia; and 15 other locations."
How many participants are being taken in for this clinical trial?
"A total of 212 participants are required for this clinical trial, all of which must meet the certain eligibility requirements. Patients can enroll at different research sites, such as Mariwalla Dermatology in West Islip, New york and Research Institute of the Southeast, LLC in West Palm Beach, Florida."
Are people with the necessary medical conditions able to sign up for this study?
"According to the latest information available on clinicaltrials.gov, this study is actively looking for participants. The original posting date was May 1st, 2022 and the listing was most recently updated on July 5th, 2022."
Who else is applying?
What state do they live in?
How old are they?
What site did they apply to?
What portion of applicants met pre-screening criteria?
How many prior treatments have patients received?
What questions have other patients asked about this trial?
Why did patients apply to this trial?
Share this study with friends
Copy Link
Messenger